豪能股份(603809):主业持续突破,航空航天与机器人注入新动力
NORTHEAST SECURITIES· 2026-01-13 06:50
Investment Rating - The report initiates coverage with an "Accumulate" rating for the company [3][5]. Core Insights - The company is a leading manufacturer of automotive components, particularly in synchronizers and differentials, with new products expected to ramp up production [1]. - The aerospace and robotics sectors are identified as new growth drivers, with the company having established a strong presence in these areas [2][3]. - The company has formed deep partnerships with numerous reputable domestic and international clients, enhancing its market position [1]. Financial Summary - Projected net profits for 2025, 2026, and 2027 are estimated at 360 million, 410 million, and 496 million respectively, with corresponding P/E ratios of 40x, 34x, and 28x [3]. - Revenue is expected to grow from 2,360 million in 2024 to 3,918 million in 2027, reflecting a compound annual growth rate (CAGR) of approximately 15.37% [4]. - The company's gross margin is projected to be around 34% in the coming years, with a net profit margin of approximately 12.7% by 2027 [4].
新和成(002001):底部已现弹性可期,新材料驱动成长新阶段
Shenwan Hongyuan Securities· 2026-01-13 06:41
上 市 公 司 -20% 0% 20% 40% 01-13 02-13 03-13 04-13 05-13 06-13 07-13 08-13 09-13 10-13 11-13 12-13 新和成 沪深300指数 (收益率) 相关研究 证券分析师 李绍程 A0230525070002 lisc@swsresearch.com 宋涛 A0230516070001 songtao@swsresearch.com 马昕晔 A0230511090002 maxy@swsresearch.com 联系人 公 司 研 究 / 公 司 深 度 证 券 研 究 报 告 | | | | --- | --- | | | | | . | 1 | | . | | | 市场数据: | 2026 年 01 月 12 日 | | | --- | --- | --- | | 收盘价(元) | | 25.36 | | 一年内最高/最低(元) | 26.28/19.52 | | | 市净率 | | 2.4 | | 股息率%(分红/股价) | | 3.55 | | 流通 A 股市值(百万元) | 77,015 | | | 上证指数/深证成指 | ...
江苏国泰(002091):首次覆盖报告:江苏纺服外贸龙头,贸易、化工双轮驱动
Haitong Securities International· 2026-01-13 06:13
Investment Rating - The report assigns an "Outperform" rating to the company, with a target price of 11.52 RMB based on a 15x PE for 2026, resulting in a target market value of 187.5 billion RMB [1][16]. Core Insights - The company is positioned as a leading player in textile trade and the electrolyte sector, benefiting from the global restructuring of consumer goods supply chains and the recovery of the new energy industry. The core trading business maintains steady growth through global capacity layout, while the chemical new materials segment is expected to contribute to earnings elasticity due to increased orders from battery clients and improved supply structure [4][13]. Financial Summary - The company forecasts total revenue for 2025-2027 to be 398.6 billion, 413.3 billion, and 425.4 billion RMB, with year-on-year growth rates of +2.3%, +3.7%, and +2.9% respectively. The net profit attributable to the parent company is projected to be 11.93 billion, 12.50 billion, and 13.07 billion RMB, with growth rates of +7.9%, +4.8%, and +4.5% respectively [14][15]. Business Overview - The company operates primarily in the textile trade, which accounts for over 90% of its revenue. The chemical business, while facing challenges, still plays a role in the overall performance. The trading segment is expected to grow steadily, while the chemical segment is projected to recover gradually as market conditions improve [25][19]. Supply Chain Strategy - The company has shifted towards a "world supply chain integration" model, with significant investments in overseas production facilities, particularly in Southeast Asia and Africa. This strategy aims to mitigate external disruptions and ensure stable core orders [4][41]. New Energy and Materials Sector - The new energy materials segment, led by the subsidiary RuTai New Materials, is focused on lithium battery materials and organic silicon. The company anticipates a recovery in this sector as supply and demand dynamics improve, despite facing price pressures in the short term [20][4].
荣昌生物(688331):RC148授权艾伯维,进入大药postBD阶段
Huaan Securities· 2026-01-13 05:33
[Table_StockNameRptType] 荣昌生物(688331) 公司点评 RC148 授权艾伯维,进入大药 post BD 阶段 [Table_Rank] 投资评级:买入(维持) | 报告日期: | 2026-1-13 | | --- | --- | | [Table_BaseData] 收盘价(元) | 95.38 | | 近 12 个月最高/最低(元)118.88/25.98 | | | 总股本(百万股) | 564 | | 流通股本(百万股) | 162 | | 流通股比例(%) | 28.7% | | 总市值(亿元) | 537.67 | | 流通市值(亿元) | 154.83 | 公司价格与沪深 300 走势比较 -100% 0% 100% 200% 300% 荣昌生物 沪深300 [Table_Author] 分析师:谭国超 执业证书号:S0010521120002 邮箱:tangc@hazq.com 分析师:任婉莹 执业证书号:S0010525060003 邮箱:renwanying@hazq.com [Table_CompanyReport] 相关报告 主要观点: ⚫[Table_ ...
隆华科技(300263):新材料板块快速增长、萃取剂项目年内完工
NORTHEAST SECURITIES· 2026-01-13 05:10
Investment Rating - The report initiates coverage with a "Buy" rating for the company [5]. Core Insights - The company is experiencing rapid growth in the new materials sector, particularly with its PMI foam materials, which are essential for various aircraft and other applications. The subsidiary, Zhaoheng Technology, achieved a revenue of 61.836 million yuan and a net profit of 30.4063 million yuan in the first half of 2025, representing year-on-year growth of 29.11% and 45.32% respectively [1]. - The extraction agent project by the subsidiary, Sannuo New Materials, is expected to commence production within the year, significantly enhancing the company's capacity and profitability in various sectors including metallurgy and battery metal recycling [2]. - The electronic new materials business is steadily growing, with products used in semiconductor manufacturing and photovoltaic applications. The company is actively developing new target materials for various advanced technologies [2]. Financial Summary - The projected revenues for the company from 2025 to 2027 are 3.015 billion yuan, 3.858 billion yuan, and 4.881 billion yuan respectively, with net profits expected to be 185 million yuan, 282 million yuan, and 421 million yuan during the same period [4]. - The company’s earnings per share are forecasted to increase from 0.18 yuan in 2025 to 0.41 yuan in 2027, indicating a strong growth trajectory [4]. - The net profit margin is expected to improve from 4.8% in 2024 to 8.6% in 2027, reflecting enhanced operational efficiency [4].
潮宏基(002345):四季度净利润中值预计1.67亿元,全年净开店163家
Guoxin Securities· 2026-01-13 05:07
国信零售观点:1)剔除菲安妮女包业务商誉减值影响的 1.71 亿元后,公司归母净利润达到 6.07-7.04 亿 元,同口径下同比增长 73.35%-101.01%,整体表现较好。2)单四季度看,预计归母净利润 1.19-2.16 亿 元,中值 1.67 亿元。3)门店拓展方面,2025 年净增门店 163 家,期末潮宏基珠宝门店总数达 1668 家。 2026 年预计开店势能依旧较强,加盟商仍有较强开店意愿。 整体上,公司四季度店效仍延续较好增速,12 月受基数走高、税改以及营销活动错期等影响略有放缓,但 随着当前临近春节旺季,以及公司产品持续上新,店效具备一定提速支撑。短期建议关注春节旺季,中长 期公司门店拓展+产品逻辑较顺。考虑公司四季度增长较好,以及费用率有望进一步优化,我们上调公司 2025-2027 年归母净利润预测至 4.91/6.28/7.36 亿元(前值分别为 4.87/5.67/6.42 亿元),对应 PE 分别 为 22.6/17.7/15.1 倍,维持"优于大市"评级。 证券研究报告 | 2026年01月13日 潮宏基(002345.SZ) 四季度净利润中值预计 1.67 亿元,全年净 ...
桐昆股份(601233):聚酯链反内卷推进,看好长丝龙头景气修复
Soochow Securities· 2026-01-13 05:06
桐昆股份(601233) 证券研究报告·公司点评报告·炼化及贸易 聚酯链反内卷推进,看好长丝龙头景气修复 2026 年 01 月 13 日 买入(首次) | [Table_EPS] 盈利预测与估值 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入(百万元) | 82,640 | 101,307 | 95,280 | 99,872 | 103,220 | | 同比(%) | 33.30 | 22.59 | (5.95) | 4.82 | 3.35 | | 归母净利润(百万元) | 797.04 | 1,201.90 | 2,031.86 | 3,486.59 | 4,006.41 | | 同比(%) | 539.10 | 50.80 | 69.05 | 71.60 | 14.91 | | EPS-最新摊薄(元/股) | 0.33 | 0.50 | 0.84 | 1.45 | 1.67 | | P/E(现价&最新摊薄) | 52.38 | 34.73 | 20.55 | 11.97 | 1 ...
中裕科技(920694):新签4881万元钢衬耐磨管订单,期待新品与海外产能释放增量
Soochow Securities· 2026-01-12 23:40
证券研究报告·北交所公司点评报告·橡胶 中裕科技(920694) 新签 4881 万元钢衬耐磨管订单,期待新品与 海外产能释放增量 增持(维持) | [Table_EPS] 盈利预测与估值 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入(百万元) | 667.60 | 599.27 | 660.76 | 761.39 | 910.32 | | 同比 | 10.03 | (10.23) | 10.26 | 15.23 | 19.56 | | 归母净利润(百万元) | 126.78 | 104.83 | 116.35 | 139.16 | 165.31 | | 同比 | 37.50 | (17.32) | 10.99 | 19.61 | 18.79 | | EPS-最新摊薄(元/股) | 0.96 | 0.79 | 0.88 | 1.05 | 1.25 | | P/E(现价&最新摊薄) | 22.04 | 26.65 | 24.01 | 20.07 | 16.90 | [Table_Ta ...
青木科技(301110):积极拓展品牌孵化业务,经营杠杆有望加速释放
海通国际· 2026-01-12 15:06
Investment Rating - The report assigns an "Outperform" rating to the company [4] Core Insights - The company is actively expanding its brand incubation business, which is expected to lead to the release of operational leverage and accelerate performance growth starting in 2026 [1][4] - Revenue and net profit are projected to grow significantly, driven by the rapid growth of the brand incubation business and stable growth in the e-commerce operation business [4][10] Financial Summary - Total revenue is forecasted to reach 15.4 billion, 24.7 billion, and 29.6 billion yuan for 2025, 2026, and 2027 respectively, with growth rates of 34%, 60%, and 20% [4][10] - Net profit attributable to the parent company is expected to be 1.33 billion, 2.47 billion, and 3.02 billion yuan for the same years, with growth rates of 47%, 86%, and 22% [4][12] - The company’s gross margin is projected to improve, reaching 57.4%, 64.8%, and 66.5% in 2025, 2026, and 2027 respectively [10][11] Business Overview - The company primarily provides e-commerce services and brand incubation and management services, collaborating with various well-known domestic and international consumer brands [16] - The brand incubation business focuses on health and pet food sectors, with significant contributions from brands like Keman Duo and Yikali [4][16][22] - The e-commerce operation business is expected to maintain steady growth, with major contributions from the apparel category and partnerships with brands like Skechers and ECCO [4][16][22] Revenue Breakdown - The brand incubation and management business is anticipated to grow rapidly, with projected revenues of 6.0 billion, 14.6 billion, and 18.8 billion yuan for 2025, 2026, and 2027, reflecting year-on-year growth rates of 96%, 143%, and 29% [4][10][12] - The e-commerce operation business is expected to generate revenues of 6.5 billion, 7.0 billion, and 7.3 billion yuan for the same years, with growth rates of 15%, 7%, and 5% [4][10][12] Valuation - The company is assigned a target price of 93.42 yuan based on a 35x PE ratio for 2026, reflecting a valuation discount compared to comparable companies [4][14]
齐鲁银行(601665):新三年的成长展望
Changjiang Securities· 2026-01-12 13:13
Investment Rating - The investment rating for Qilu Bank is "Buy" and is maintained [8] Core Views - Qilu Bank's stock price has undergone sufficient valuation adjustment since Q3 2025, influenced by market trading factors. The bank is entering a new three-year planning cycle in 2026, with management focusing on stable and sustainable growth. In the current macroeconomic environment, high-quality city commercial banks with stable growth capabilities are considered scarce assets. The bank is expected to achieve a trillion-scale asset size in the new three-year plan [5][11] - Loan growth is projected to be between 13% and 15% from 2025 to 2027, with a continuous increase in loan market share. Net interest income is expected to drive revenue growth. The long-term growth path is clear, and there is room for valuation recovery in PB-ROE [11][20] - The bank's dividend yield is expected to be 4.65% in 2025 and 5.20% in 2026, meeting the needs of long-term investors [11] Summary by Sections Company Overview - Qilu Bank has a long-standing management philosophy focused on stable and sustainable growth. The bank's asset scale has achieved an annual compound growth rate of 16.2% over the past three years, with profit growth at 16.9%, ranking among the top in the banking sector. The bank aims to reach a trillion in assets by 2027, requiring an annual growth rate of at least 12.2% over the next two years [11][20] Loan and Revenue Growth - The bank's loan growth is expected to be between 13% and 15% from 2025 to 2027. As of mid-2025, Qilu Bank's loan market share in Shandong province is 2.3%, indicating significant room for improvement compared to other leading city commercial banks. The bank's credit structure is primarily focused on state-owned enterprises, with retail loan demand remaining weak [11][20] Asset Quality - Qilu Bank's asset quality is at its best since its listing, with a continuous decline in non-performing loan (NPL) ratios and a net NPL generation rate dropping to a historical low of 0.31% (annualized) in the first half of 2025. The bank's credit cost is expected to decrease further, allowing for double-digit profit growth in 2026 [11][20] Valuation and Dividend - The bank's PB valuation is projected to be 0.71x in 2025 and 0.65x in 2026, indicating undervaluation relative to a 12% ROE. The bank may slightly increase its dividend payout ratio in 2025 to offset the dilution effect of convertible bonds, with expected dividend yields of 4.65% and 5.20% for 2025 and 2026, respectively [11][20]